Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Share Price
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 40.30 CNY | +0.80% |
|
-1.90% | -11.66% |
| Market Cap | 26.45B 3.97B 3.56B 3.27B 2.97B 5.54B 377B 5.65B 39.04B 15.67B 198B 14.91B 14.6B 626B | P/E 2026 * |
30.1x | P/E 2027 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise Value | 26.45B 3.97B 3.56B 3.27B 2.97B 5.54B 377B 5.65B 39.04B 15.67B 198B 14.91B 14.6B 626B | EV / Sales 2026 * |
5.36x | EV / Sales 2027 * | 4.94x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.80% | ||
| 1 week | -1.90% | ||
| Current month | +14.10% | ||
| 1 month | +14.10% | ||
| 3 months | +5.22% | ||
| 6 months | -0.74% | ||
| Current year | -11.66% |
| 1 week | 39.25 |  | 42.05 |
| 1 month | 35.16 | | 42.7 |
| Current year | 33.83 | | 48.2 |
| 1 year | 33.83 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 03/09/2026 |
Jian Ma
DFI | Director of Finance/CFO | 42 | - |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Zhou
BRD | Director/Board Member | 56 | 14/05/2019 |
Min Guo
CHM | Chairman | 55 | 05/09/2021 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 09/12/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -1.90% | -4.43% | +24.19% | 3.97B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.64% | +4.96% | +41.49% | +77.24% | 426.59B | |
| Weighted average by Cap. | +1.19% | +6.59% | +50.83% | +98.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 741M 664M 610M 553M 1.03B 70.34B 1.05B 7.28B 2.92B 37B 2.78B 2.72B 117B | 5.35B 804M 720M 662M 600M 1.12B 76.34B 1.14B 7.9B 3.17B 40.16B 3.02B 2.95B 127B |
| Net income | 1.04B 156M 139M 128M 116M 217M 14.78B 221M 1.53B 614M 7.77B 584M 572M 24.52B | 1.18B 178M 159M 147M 133M 248M 16.89B 253M 1.75B 702M 8.89B 668M 653M 28.02B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
Calendar
07:00am
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CN¥40.30 | +0.80% | 5,880,222 |
| 29/10/26 | CN¥39.98 | -1.26% | 5,814,173 |
| 28/10/26 | CN¥40.49 | -0.91% | 4,142,673 |
| 27/10/26 | CN¥40.86 | -2.13% | 3,842,700 |
| 26/10/26 | CN¥41.75 | +1.63% | 6,530,222 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
40.30
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
